Results 171 to 180 of about 126,259 (241)

Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized With Respiratory Syncytial Virus. [PDF]

Clin Infect Dis
Sudnik P, Walsh EE, Branche AR, Islam MR, Falsey AR.   +4 more
europepmc   +1 more source

Programmed cell death in human respiratory syncytial virus infection. [PDF]

Front Cell Infect Microbiol
Yao P, Ma C, Liu C.
europepmc   +1 more source

Investigating the Role of A20 in Respiratory Syncytial Virus Immunopathogenesis in a BALB/c Mouse Model. [PDF]

Immun Inflamm Dis
Tahamtan A, Yasaghi M, Samadizadeh S, Nikoo HR, Yamchi A, Salimi V.   +5 more
europepmc   +1 more source

Stratify severe risk in children with respiratory syncytial virus pneumonia-A retrospective study based on machine learning and SHAP interpretation. [PDF]

Front Pediatr
Pan JA, Yang WH, Wu CF, Zhou M, Liu J, Chen LN.   +5 more
europepmc   +1 more source

Pathological Characteristics of the Lung and Brain in Cotton Rats and BALB/c Mice Infected with Respiratory Syncytial Virus. [PDF]

Viruses
Wang Z, Jiang B, Huang Z, Liu M, Li Z, Long W, Shen H, Fan S, Ye Y, Huang Z.   +9 more
europepmc   +1 more source

Identification of key clinical features for pediatric respiratory syncytial virus infection using machine learning. [PDF]

BMC Pediatr
Miyagi Y, Morimoto Y, Satake E, Iwashima S, Yano Y, Urabe R, Kitagawa A, Kato H, Kin K.   +8 more
europepmc   +1 more source

Respiratory syncytial virus mRNA vaccine-induced immunity and protection against subgroups A and B in mice. [PDF]

Immunohorizons
Lee S, Yoon J, Shooter S, Pak DS, Ha B, Rostad CA, Anderson LJ, Schinazi RF, Kim B.   +8 more
europepmc   +1 more source

The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019-2023. [PDF]

Influenza Other Respir Viruses
Kenji O, Motta F, Williams T, Wolter N, Barr IG, Dapat C, Zambon M, Mosscrop L, Shang M, Nikisins S, Hirve S, Zhang W, WHO RSV Surveillance Group.   +12 more
europepmc   +1 more source

Cost-Effectiveness of Bivalent Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Italy. [PDF]

Clinicoecon Outcomes Res
Di Matteo S, Bonanni P, Boccalini S, Di Virgilio R, Fogliati EL, Colombo GL.   +5 more
europepmc   +1 more source